BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 23061808)

  • 21. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
    Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
    Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic testing in pheochromocytoma: increasing importance for clinical decision making.
    Bornstein SR; Gimenez-Roqueplo AP
    Ann N Y Acad Sci; 2006 Aug; 1073():94-103. PubMed ID: 17102076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
    Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
    Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.
    McInerney-Leo AM; Marshall MS; Gardiner B; Benn DE; McFarlane J; Robinson BG; Brown MA; Leo PJ; Clifton-Bligh RJ; Duncan EL
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):25-33. PubMed ID: 24102379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
    Bertherat J; Gimenez-Roqueplo AP
    Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
    Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma.
    Burnichon N; Buffet A; Parfait B; Letouzé E; Laurendeau I; Loriot C; Pasmant E; Abermil N; Valeyrie-Allanore L; Bertherat J; Amar L; Vidaud D; Favier J; Gimenez-Roqueplo AP
    Hum Mol Genet; 2012 Dec; 21(26):5397-405. PubMed ID: 22962301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
    Benn DE; Richardson AL; Marsh DJ; Robinson BG
    Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.
    Cascón A; López-Jiménez E; Landa I; Leskelä S; Leandro-García LJ; Maliszewska A; Letón R; de la Vega L; García-Barcina MJ; Sanabria C; Alvarez-Escolá C; Rodríguez-Antona C; Robledo M
    Horm Metab Res; 2009 Sep; 41(9):672-5. PubMed ID: 19343621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
    Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
    Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.
    Welander J; Andreasson A; Juhlin CC; Wiseman RW; Bäckdahl M; Höög A; Larsson C; Gimm O; Söderkvist P
    J Clin Endocrinol Metab; 2014 Jul; 99(7):E1352-60. PubMed ID: 24694336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
    Opocher G; Conton P; Schiavi F; Macino B; Mantero F
    Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term prognosis of patients with pediatric pheochromocytoma.
    Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
    Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
    Gaal J; Burnichon N; Korpershoek E; Roncelin I; Bertherat J; Plouin PF; de Krijger RR; Gimenez-Roqueplo AP; Dinjens WN
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1274-8. PubMed ID: 19915015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary paragangliomas.
    Raygada M; Pasini B; Stratakis CA
    Adv Otorhinolaryngol; 2011; 70():99-106. PubMed ID: 21358191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pheochromocytoma: an update on genetics and management.
    Karagiannis A; Mikhailidis DP; Athyros VG; Harsoulis F
    Endocr Relat Cancer; 2007 Dec; 14(4):935-56. PubMed ID: 18045948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations.
    Mora J; Cascón A; Robledo M; Catala A
    Pediatr Blood Cancer; 2006 Nov; 47(6):785-9. PubMed ID: 16304664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hereditary pheochromocytoma-associated syndromes. Part 1].
    Yukina MY; Troshina EA; Beltsevich DG
    Ter Arkh; 2015; 87(9):102-105. PubMed ID: 26591561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma.
    Abermil N; Guillaud-Bataille M; Burnichon N; Venisse A; Manivet P; Guignat L; Drui D; Chupin M; Josseaume C; Affres H; Plouin PF; Bertherat J; Jeunemaître X; Gimenez-Roqueplo AP
    J Clin Endocrinol Metab; 2012 May; 97(5):E805-9. PubMed ID: 22419703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
    Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen JL; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH;
    JAMA Oncol; 2017 Sep; 3(9):1204-1212. PubMed ID: 28384794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.